BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ebata T, Nagino M, Nishio H, Igami T, Yokoyama Y, Nimura Y. Pancreatic and duodenal invasion in distal bile duct cancer: paradox in the tumor classification of the American Joint Committee on Cancer. World J Surg 2007;31:2008-15. [PMID: 17661132 DOI: 10.1007/s00268-007-9173-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Skalicky P, Urban O, Ehrmann J, Svebisova H, Klos D, Tesarikova J, Neoral C, Knapkova K, Lovecek M. The short- and long-term outcomes of pancreaticoduodenectomy for distal cholangiocarcinoma. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2021. [PMID: 34467956 DOI: 10.5507/bp.2021.043] [Reference Citation Analysis]
2 Tamura S, Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Ohgi K, Sasaki K, Sugino T, Uesaka K. The evaluation of the 8th and 7th edition of the American joint committee on cancer tumor classification for distal cholangiocarcinoma: the proposal of a modified new tumor classification. HPB (Oxford) 2021;23:1209-16. [PMID: 33358564 DOI: 10.1016/j.hpb.2020.12.001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Nitta N, Ohgi K, Sugiura T, Okamura Y, Ito T, Yamamoto Y, Ashida R, Sasaki K, Uesaka K. Prognostic Impact of Pancreatic Invasion in Duodenal Carcinoma: A Single-Center Experience. Ann Surg Oncol 2020;27:4553-60. [PMID: 32367502 DOI: 10.1245/s10434-020-08512-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Seita K, Ebata T, Mizuno T, Maeda A, Yamaguchi R, Kurumiya Y, Sakamoto E, Hiramatsu K, Ando M, Nagino M. Phase 2 Trial of Adjuvant Chemotherapy With S - 1 for Node-Positive Biliary Tract Cancer (N-SOG 09). Ann Surg Oncol 2020;27:2348-56. [PMID: 32180066 DOI: 10.1245/s10434-020-08355-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
5 Beetz O, Klein M, Schrem H, Gwiasda J, Vondran FWR, Oldhafer F, Cammann S, Klempnauer J, Oldhafer KJ, Kleine M. Relevant prognostic factors influencing outcome of patients after surgical resection of distal cholangiocarcinoma. BMC Surg. 2018;18:56. [PMID: 30103720 DOI: 10.1186/s12893-018-0384-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
6 Min KW, Kim DH, Son BK, Moon KM, Kim EK, Oh YH, Kwon MJ, Choi HS. Dual-organ invasion is associated with a lower survival rate than single-organ invasion distal bile duct cancer: A multicenter study. Sci Rep 2018;8:10826. [PMID: 30018404 DOI: 10.1038/s41598-018-29205-z] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Aoyama H, Ebata T, Hattori M, Takano M, Yamamoto H, Inoue M, Asaba Y, Ando M, Nagino M, Aoba T, Kaneoka Y, Arai T, Shimizu Y, Kiriyama M, Sakamoto E, Miyake H, Takara D, Shirai K, Ohira S, Kobayashi S, Kato Y, Yamaguchi R, Hayashi E, Miyake T, Mizuno S, Sato T, Suzuki K, Hashimoto M, Kawai S, Matsubara H, Kato K, Yokoyama S, Suzumura K; Nagoya Surgical Oncology Group. Reappraisal of classification of distal cholangiocarcinoma based on tumour depth. British Journal of Surgery 2018;105:867-75. [DOI: 10.1002/bjs.10869] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
8 Ito Y, Abe Y, Egawa T, Kitago M, Itano O, Kitagawa Y. Predictive Factors of Early Recurrence in Patients with Distal Cholangiocarcinoma after Pancreaticoduodenectomy. Gastroenterol Res Pract 2018;2018:6431254. [PMID: 29849596 DOI: 10.1155/2018/6431254] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
9 Han NY, Kim JY, Kim MJ, Park BJ, Sung DJ, Sim KC, Cho SB, Kim DS. Validation of Feasibility of Magnetic Resonance Imaging for the Measurement of Depth of Tumor Invasion in Distal Bile Duct Cancer According to the New American Joint Committee on Cancer Staging System. Acad Radiol 2017;24:1526-34. [PMID: 28780173 DOI: 10.1016/j.acra.2017.06.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
10 Maeta T, Ebata T, Hayashi E, Kawahara T, Mizuno S, Matsumoto N, Ohta S, Nagino M; Nagoya Surgical Oncology Group. Pancreatoduodenectomy with portal vein resection for distal cholangiocarcinoma. Br J Surg 2017;104:1549-57. [PMID: 28782798 DOI: 10.1002/bjs.10596] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
11 Komaya K, Ebata T, Shirai K, Ohira S, Morofuji N, Akutagawa A, Yamaguchi R, Nagino M; Nagoya Surgical Oncology Group. Recurrence after resection with curative intent for distal cholangiocarcinoma. Br J Surg. 2017;104:426-433. [PMID: 28138968 DOI: 10.1002/bjs.10452] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 9.0] [Reference Citation Analysis]
12 Warner WA, Ramcharan W, Harnanan D, Umakanthan S, Maharaj R. A case of distal extrahepatic cholangiocarcinoma with two positive resection margins. Oncol Lett 2016;12:4075-9. [PMID: 27895774 DOI: 10.3892/ol.2016.5174] [Reference Citation Analysis]
13 Wellner UF, Shen Y, Keck T, Jin W, Xu Z. The survival outcome and prognostic factors for distal cholangiocarcinoma following surgical resection: a meta-analysis for the 5-year survival. Surg Today 2017;47:271-9. [DOI: 10.1007/s00595-016-1362-0] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
14 Wiltberger G, Krenzien F, Benzing C, Atanasov G, Klein F, Hau HM, Feldbrügge L, Pratschke J, Schmelzle M, Jonas S. Prognostic Accuracy of the Seventh Edition of the TNM Classification Compared with the Fifth and Sixth Edition for Distal Cholangiocarcinoma. Ann Surg Oncol 2016;23:1320-6. [PMID: 26607711 DOI: 10.1245/s10434-015-4999-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
15 Miura F, Sano K, Amano H, Toyota N, Wada K, Tokairin T, Kondo F, Hayano K, Matsubara H, Takada T. Is it possible to define early distal cholangiocarcinoma? Langenbecks Arch Surg 2016;401:25-32. [DOI: 10.1007/s00423-015-1351-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
16 Zhou Y, Liu S, Wu L, Wan T. Survival after surgical resection of distal cholangiocarcinoma: A systematic review and meta-analysis of prognostic factors. Asian J Surg. 2017;40:129-138. [PMID: 26337377 DOI: 10.1016/j.asjsur.2015.07.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
17 Takahashi Y, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Nimura Y, Nagino M. Surgery for Recurrent Biliary Tract Cancer: A Single-center Experience With 74 Consecutive Resections. Ann Surg. 2015;262:121-129. [PMID: 25405563 DOI: 10.1097/sla.0000000000000827] [Cited by in Crossref: 43] [Cited by in F6Publishing: 21] [Article Influence: 6.1] [Reference Citation Analysis]
18 Miura F, Sano K, Amano H, Toyota N, Wada K, Yoshida M, Hayano K, Matsubara H, Takada T. Evaluation of portal vein invasion of distal cholangiocarcinoma as borderline resectability. J Hepatobiliary Pancreat Sci 2015;22:294-300. [DOI: 10.1002/jhbp.198] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
19 Wang Y, Duan B, Yan L, Shen C, Wu B, Luo J, Shen F, Zhao G. Long-term outcome after surgical resection for cholangiocarcinoma and prognostic index value. Surgeon 2016;14:38-43. [PMID: 25263386 DOI: 10.1016/j.surge.2014.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
20 Iso Y, Kita J, Kato M, Shimoda M, Kubota K. When hepatic-side ductal margin is positive in N+ cases, additional resection of the bile duct is not necessary to render the negative hepatic-side ductal margin during surgery for extrahepatic distal bile duct carcinoma. Med Sci Monit 2014;20:471-5. [PMID: 24657986 DOI: 10.12659/MSM.889714] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
21 Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y, Nagino M. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients. Ann Surg. 2012;256:297-305. [PMID: 22750757 DOI: 10.1097/sla.0b013e31826029ca] [Cited by in Crossref: 129] [Cited by in F6Publishing: 37] [Article Influence: 12.9] [Reference Citation Analysis]
22 Kobayashi H, Murakami Y, Uemura K, Sudo T, Hashimoto Y, Kondo N, Sueda T. Human equilibrative nucleoside transporter 1 expression predicts survival of advanced cholangiocarcinoma patients treated with gemcitabine-based adjuvant chemotherapy after surgical resection. Ann Surg 2012;256:288-96. [PMID: 22580938 DOI: 10.1097/SLA.0b013e3182536a42] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
23 Qiao Q, Zhang T, Guo J, Zhan H, Zhao J, Liu Y, Wan Y, Leng X, Zhao Y. Prognostic Factors after Pancreatoduodenectomy for Distal Bile Duct Cancer. The American Surgeon 2011;77:1445-8. [DOI: 10.1177/000313481107701130] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
24 Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;8:512-522. [PMID: 21808282 DOI: 10.1038/nrgastro.2011.131] [Cited by in Crossref: 404] [Cited by in F6Publishing: 399] [Article Influence: 36.7] [Reference Citation Analysis]
25 Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;8:512-522. [PMID: 21808282 DOI: 10.1038/nrgastro.2011.131.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N, Sakabe R, Ohge H, Sueda T. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol 2011;18:651-8. [PMID: 20945107 DOI: 10.1245/s10434-010-1325-4] [Cited by in Crossref: 143] [Cited by in F6Publishing: 128] [Article Influence: 11.9] [Reference Citation Analysis]
27 Kim K, Chie EK, Jang JY, Kim SW, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW. Is duodenal invasion a relevant prognosticator in patients undergoing adjuvant chemoradiotherapy for distal common bile duct cancer? Int J Radiat Oncol Biol Phys 2010;77:1186-90. [PMID: 19962835 DOI: 10.1016/j.ijrobp.2009.06.033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
28 Choi SB, Park SW, Kim KS, Choi JS, Lee WJ. The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection. J Surg Oncol. 2009;99:335-342. [PMID: 19226533 DOI: 10.1002/jso.21238] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
29 Veillette G, Castillo CF. Distal Biliary Malignancy. Surgical Clinics of North America 2008;88:1429-47. [DOI: 10.1016/j.suc.2008.07.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
30 Bahra M, Jacob D, Langrehr JM, Neumann UP, Neuhaus P. Carcinoma of the distal and middle bile duct: surgical results, prognostic factors, and long-term follow-up. J Hepatobiliary Pancreat Surg 2008;15:501-7. [DOI: 10.1007/s00534-007-1308-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]